Biosimilar medicines in inflammatory bowel disease

Tidsskr Nor Laegeforen. 2014 Apr 29;134(8):819-20. doi: 10.4045/tidsskr.14.0192.
[Article in English, Norwegian]
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / economics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use
  • Biosimilar Pharmaceuticals* / economics
  • Biosimilar Pharmaceuticals* / standards
  • Biosimilar Pharmaceuticals* / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab
  • Therapeutic Equivalency

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals
  • Infliximab